REFERENCES
- Sanchorawala V Light-chain (AL) amyloidosis: Diagnosis and treatment Clin J Am Soc Nephrol. 2006;1:1331–1341.
- Petrakis I, Stylianou K, Mavroeidi V, Biopsy-proven resolution of renal light-chain deposition disease after autologous stem cell transplantation Nephrol Dial Transplant. 2010;25:2020–2023.
- Komatsuda A, Wakui H, Ohtani H, Disappearance of nodular mesangial lesions in a patient with light chain nephropathy after long-term chemotherapy Am J Kidney Dis. 2000;35:E9.
- Hotta O, Taguma Y Resolution of nodular glomerular lesions in a patient with light-chain nephropathy Nephron. 2002;91:504–505.
- Royer B, Arnulf B, Martinez F, High dose chemotherapy in light chain or light and heavy chain deposition disease Kidney Int. 2004;65:642–648.
- Crowley S, Feinfeld DA, Janis R Resolution of nephrotic syndrome and lack of progression of heroin-associated renal amyloidosis AJKD. 1989;13:333–335.
- Simsek I, Kaya A, Erdem H, Pay S, Yenicesu M, Dinc A No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy J Nephrol. 2010;23:119–123.
- Mandreoli M, Casanova S, Vianelli N, Pasquali S, Zucchelli P Remission of nephrotic syndrome due to AA Amyloidosis and initiation of glomerular repair after surgical resection of localized Castleman’s disease Nephron. 2002;90:336–340.
- Lachmann HJ, Goodman HJB, Gilbertson JA, Natural history and outcome in systemic AA amyloidosis NEJM. 2007;356:2361–2371.
- Bodin K, Ellmerich S, Kahan MC, Antibodies to human serum amyloid P component eliminate visceral amyloid deposits Nature. 2010;468:93–97.
- Zeier M, Perz J, Linke RP, No regression of renal amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement Nephrol Dial Transplant. 2003;18:2644–2647.
- Sanada S, Suzuki M, Shindo T, Clinical and histological responses of renal amyloidosis to high-dose melphalan supported by autologous stem cell transplantation Nephrol Dial Transplant. 2008;23:747–750.
- Patriarca F, Geromin A, Fanin R, Damiani D, Sperotto A, Baccarani M Improvement of amyloid-related symptoms after autologous stem cell transplantation in a patient with hepatomegaly, macroglossia and purpura Bone Marrow Transplant. 1999;4:433–435.
- Van Buren M, Hené RJ, Verdonck LF, Verzijlbergen FJ, Lokhorst HM Clinical remission after syngeneic bone marrow transplantation in a patient with AL amyloidosis Ann Int Med. 1995;122:508–510.
- Qian Q, Nasr SH, Fidler ME, Cornell LD, Sethi S De novo AL amyloidosis in the kidney allograft Am J Transplant. 2011;11:606–612.
- Dember LM Amyloid-associated kidney disease JASN. 2006;17:3458–3471.
- Dember LM, Sanchorawala V, Seldin DC, Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on AL amyloidosis-associated renal disease Ann Intern Med. 2001;134:746–753.
- Dember LM. Modern treatment of amyloidosis: Unresolved questions J Am Soc Nephrol. 2009;20:469–472.
- Amdur RL, Chawla LS, Amodeo S, Kimmel PL, Palant CE. Outcomes following diagnosis of acute renal failure in U.S. veterans: Focus on acute tubular necrosis Kidney Int. 2009;76:1089–1097.
- Venkatachalam MA, Griffin KA, Lan R, Geng H, Saikumar P, Bidani AK Acute kidney injury: A springboard for progression in chronic kidney disease Am J Physiol Renal Physiol. 2010;298:F1078–F1094.
- Fadia A, Casserly LF, Sanchorawala V, Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis Kidney Int. 2003;63:1868–1873.
- Leung N, Slezak JM, Bergstralh EJ, Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation AJKD. 2005;45:102–111.